HomeOwner SearchCategory Search
Visit USCOCardiovascular Drugs and Therapy [Published: 2014-07-21. Issue: vol. 28, no. 3, 2014]
Serial Registration
Copyright Title
Cardiovascular Drugs and Therapy [Published: 2014-07-21. Issue: vol. 28, no. 3, 2014]
Status
Published
on 30 Jul 2014
Year of Creation
2014
Copyright Claimant
Springer Science+Business Media LLC
Registration Number
TX0007910222
on 30 Jul 2014Copyright Summary
The U.S. Copyright record (Registration Number: TX0007910222) dated 30 Jul 2014, pertains to an electronic file (eService) titled "Cardiovascular Drugs and Therapy [Published: 2014-07-21. Issue: vol. 28, no. 3, 2014]" created in 2014. The copyright holder is Springer Science+Business Media LLC, known for their creative contributions in serial registration. For any inquiries concerning this copyrighted material, kindly reach out to Springer Science+Business Media LLC.
Application Details
Registration Number
TX0007910222
Registration Date
7/30/2014
Year of Creation
2014
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
Springer Science+Business Media LLC
First Publication Nation
United States
ISSN
0920-3206
Notes
Copyright Local Holdings: vol. 28, no. 3, 2014 Created 2014 Pub. 2014-07-21 Reg. 2014-07-30 TX0007910222 CDAV
Statements
Application Title Statement: Cardiovascular Drugs and Therapy
Author Statement: Springer Science+Business Media LLC employer for hire Domicile: United States Citizenship: United States Authorship: contribution(s) to a collective work
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.